Pay in 4 interest-free payments of $5.65 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Prescribing population We identified patients aged 18 years or older who were prescribed a GLP-1 between January 2024 and February 2026
For example, the incidence of AP in children is increasing rapidlyby approximately 5.44% per yearand is gradually approaching that reported in adults
Maintaining Weight Loss: The Efficacy of Long-Term Tirzepatide Therapy Obesity is the most prevalent chronic condition worldwide, affecting more than 13% of the adult population
Penn Researchers Use AI to Surface Unreported GLP-1 Side Effects in Reddit Posts AI, Research and Innovation / April 10, 2026 By using AI to analyze more than 400,000 Reddit posts, Penn researchers have identified patient-reported symptoms associated with GLP-1s, the popular weight-loss and diabetes drugs semaglutide and tirzepatide, that may not be fully captured in clinical trials or regulatory documents
US$ 24.47
US$ 28.13
US$ 23.15
US$ 23.76
US$ 21.39
US$ 20.85
US$ 22.81
